EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Laseroptek Co., Ltd. (199550) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Laseroptek Co., Ltd. KRW 798, price KRW 3,255, upside -75.5%, quality 21 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · KR

LC Thin data Sep 24, 2026

Laseroptek Co., Ltd.

199550 · KQ

Weakest SetupStrongly overvalued and low quality.

!Fair value 797.88 KRW · Strongly overvalued (−75%)
!Quality 21/100
!Weak Growth (revenue 3y −5.1 %/yr)
!Loss-making · -34.3% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (2/8)
!Narrow moat 8/100
!Evidence only low, so the estimate is less certain
Watch Laseroptek Co., Ltd. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

16,234 KRW 2,255 KRW Fair Value 797.88 KRW Feb 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

32‑month range 2,255 KRW – 16,234 KRW · fair‑value band 526.60 KRW – 997.35 KRW · the 3,255 KRW price screens above the 797.88 KRW fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Laseroptek Co. in your weekly email

Every Wednesday you see whether Laseroptek Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea.

Show more

Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.

Stock analysis

Laseroptek Co., Ltd. (199550) currently trades at 3,255 KRW, while our model-based Fair Value estimate is 797.88 KRW, implying the stock looks roughly 308.0% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 526.60 KRW (bear) to 997.35 KRW (bull), the price of 3,255 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Laseroptek Co., Ltd. reported revenue of 25.7B KRW in FY2025 versus 18.7B KRW in FY2021, a compound +8.3%/yr. Reported net income was −10.7B KRW in FY2025.

Key figures

Market cap 43.1B KRW (≈ $31.7M) · P/S ratio 1.49 · Net margin −41.8% · Return on equity −36.2% · Return on assets (EBIT) −0.7% · Operating margin −30.7% · Revenue (TTM) 26.8B KRW · Revenue growth (YoY) +20.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).

What moves the price

The share trades about 53% below its 52-week high and 44% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −75%, 199550 screens richer than that median.

Fair Value models

Bear 526.60 KRW Fair Value 797.88 KRW Bull 997.35 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 747.14 KRW 1,001 KRW 1,494 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 747.14 KRW 1,001 KRW 1,494 KRW 54

Open the full fair value analysis →

Notify me when 199550 reaches fair value

Put 199550 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 21/100

Of which business quality 26 · Market factors (momentum, volatility) 25

Profitability 19
Margins and returns on capital today
Quality Growth 9
Are margins and returns improving?
Cashflow 2
Earnings quality: real cash, not paper profit
Fin. Strength 57
Balance sheet, leverage, solvency risk
Investment 43
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 16
Price trend over the last 3–12 months (market factor)
52W Momentum 10
Distance to the 52-week high (market factor)
Net Issuance 26
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−22.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.5% (2021) → −46.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

199550 screens 308% overvalued. Compare with Abbott Laboratories, →

Compare Laseroptek Co., Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 26 · Bottom 25%
Fair Value upside −76% · Bottom 25%
Profitability
Return on assets −19% · Bottom 25%
Net margin (TTM) −34% · Bottom 25%
Operating margin (TTM) −31% · Bottom 25%
Growth and dividend
Revenue growth 21% · Top 25%
Balance sheet
Debt / equity 0.01× · Below median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 10
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)0 · sector 7
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 40

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $103.49 $74.79 −28%
Stryker Corporation SYK $273.40 $300.74 +10%
Medtronic plc MDT $89.30 $65.57 −27%
Boston Scientific Corporation BSX $44.62 $49.08 +10%
Edwards Lifesciences Corporation EW $86.82 $82.04 −6%
Siemens Healthineers AG SHL €37.21 €35.22 −5%
DexCom, Inc DXCM $87.73 $96.50 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Laseroptek Co., Ltd. · Fair Value
797.88 KRW −308%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Laseroptek Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/199550

Frequently asked questions

Is Laseroptek Co., Ltd. (199550) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 797.88 KRW versus a price of 3,255 KRW, about −75% upside (overvalued).
What is the fair value of 199550?
Our model-based fair value for Laseroptek Co., Ltd. is 797.88 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 3,255 KRW.
What is the quality score of 199550?
Laseroptek Co., Ltd. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Laseroptek Co., Ltd. (199550)?
Our model-based price target is the fair value of 797.88 KRW (as of Sep 24, 2026) from 1 valuation models. Cautious scenario 526.60 KRW, optimistic scenario 997.35 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Laseroptek Co., Ltd. stock forecast for 2026?
Our models put fair value at 797.88 KRW, about −75% upside versus a price of 3,255 KRW (overvalued). Cautious scenario 526.60 KRW, optimistic scenario 997.35 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Laseroptek Co., Ltd. (199550)?
Laseroptek Co., Ltd. reported trailing-twelve-month revenue of about 26.8B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Laseroptek Co., Ltd. (199550)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Laseroptek Co., Ltd. it is 797.88 KRW per share (as of Sep 24, 2026), against a price of 3,255 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Laseroptek Co., Ltd. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 199550 trades above its calculated fair value: price 3,255 KRW, fair value 797.88 KRW, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 199550?
No. The price is what the market pays today (3,255 KRW); the fair value is what the company's own numbers justify (797.88 KRW). For Laseroptek Co., Ltd. the two are 2,457 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Laseroptek Co., Ltd. worth?
The market values Laseroptek Co., Ltd. at about 43.1B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 3,255 KRW; our models calculate a fair value of 797.88 KRW per share.
What do the bullish and bearish scenarios say about 199550?
Our models span a range for Laseroptek Co., Ltd.: cautious scenario 526.60 KRW, base 797.88 KRW, optimistic 997.35 KRW per share (as of Sep 24, 2026, price 3,255 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Laseroptek Co., Ltd. (199550)?
Balance-sheet figures for Laseroptek Co., Ltd. (as of Sep 24, 2026): return on equity −36.2%, debt of 0.01 per unit of equity. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is 199550 from its 52-week high?
Laseroptek Co., Ltd. trades at 3,255 KRW, about 53% below its 52-week high of 6,955 KRW and 44% above the low of 2,255 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 797.88 KRW is for.
Which stocks are comparable to Laseroptek Co., Ltd.?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Laseroptek Co., Ltd. stock attractive at the current price?
The data as of Sep 24, 2026: price 3,255 KRW, calculated fair value 797.88 KRW (−75%), Quality Score 21/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 199550 calculated?
We run Laseroptek Co., Ltd. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 797.88 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Laseroptek Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Laseroptek Co., Ltd. (199550)?
The closing price on Sep 23, 2026 was 3,255 KRW. Our model-based fair value is 797.88 KRW, about −75% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Laseroptek Co., Ltd. right now?
The price sits above even our optimistic bull case (997.35 KRW). The favourable scenario is already priced in. Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (526.60 KRW to 997.35 KRW) leaves room in how you read the outcome.

Key figures of Laseroptek Co., Ltd.

How large is the market capitalisation of Laseroptek Co., Ltd. (199550)?
The market capitalisation of Laseroptek Co., Ltd. is 43.1B KRW (≈ $31.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Laseroptek Co., Ltd. (199550)?
The price-to-sales ratio of Laseroptek Co., Ltd. is 1.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Laseroptek Co., Ltd. (199550)?
The net margin of Laseroptek Co., Ltd. is −41.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Laseroptek Co., Ltd. (199550)?
The return on equity (ROE) of Laseroptek Co., Ltd. is −36.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Laseroptek Co., Ltd. (199550)?
On an EBIT basis the return on assets of Laseroptek Co., Ltd. is −0.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Laseroptek Co., Ltd. (199550)?
The operating margin of Laseroptek Co., Ltd. is −30.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Laseroptek Co., Ltd. (199550)?
Revenue at Laseroptek Co., Ltd. is growing +20.8% versus a year earlier (3y avg −5.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Laseroptek Co., Ltd. (199550) generate?
The free cash flow of Laseroptek Co., Ltd. is −7.1B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Laseroptek Co., Ltd. (199550) carry?
The net debt of Laseroptek Co., Ltd. is 1.3B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Laseroptek Co., Ltd. in the live analysis

One click puts Laseroptek Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.